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With the goal of rapidly accessing tetrahydroquinoline-based natural-product-like polycyclic architectures,
herein, we report an unprecedented, in situ, stereocontrolled Aza Michael approach in solution and on the
solid phase. The mild reaction conditions required to reach the desired target are highly attractive for the
use of this method in library generation. To our knowledge, this approach has not been used before, and it
opens a novel route leading to a wide variety of tetrahydroquinoline-derived bridged tricyclic derivatives.
Introduction
The dissection of protein-protein interaction-based signal-
ing networks using small molecules is an activity of an
immense interest.1-3 In general, these interactions are
complex, dynamic in nature, and present tremendous chal-
lenges in developing an understanding of their role at the
molecular level.4,5 Because small molecules have the ability
to modulate these interactions in a reversible, temporal, and
nondestructive manner, there is a growing desire to use small
molecules to obtain a better understanding of multiple
protein-protein interaction-based signaling networks.6-8 In
the absence of the structural information of a protein involved
in protein-protein interactions, high-throughput generation
of small-molecule chemical probes remains the method of
choice. In particular, inspired by bioactive natural products
that have been shown to act as inhibitors of protein-protein
interactions, the development of solid-phase synthesis meth-
ods leading to the high-throughput generation of natural-
product-like compounds seems to be an attractive under-
taking.9-11
With the goal of having rapid access to tetrahydroquinoline
alkaloid, natural-product-like, polycyclic architectures, we
reveal a method that uses an unprecedented in situ aza
Michael reaction to obtain this objective. The wide abun-
dance of quinoline and tetrahydroquinoline alkaloid natural
products showing promising properties for modulating
protein-protein interactions12 was the motivation behind the
development of this method. Another objective was to
validate our hypothesis that the compounds generated from
this project were highly likely to yield interesting biological
properties because these derivatives were anticipated to
occupy the chemical space currently being championed by
quinoline and tetrahydroquinoline alkaloids.13
Results and Discussion
A practical enantioselectiVe synthesis of a highly func-
tionalized, tetrahydroaminoquinoline-derived artificial amino
acid, 1 (Figure 1) was previously reported by us.14,15 This
scaffold is highly versatile and contains several attractive
features. These include (i) the presence of orthogonally
protected functional groups, (ii) â- and δ-amino acid
functionality, (iii) 1,2-trans-amino alcohol moiety, and (iv)
1,3-hydroxyl carboxyl ester functionality. The phenolic
hydroxyl group provided a site that could be used for
immobilization of the scaffold onto the solid support.
Furthermore, as shown in compound 2, an extension of the
side chain to obtain an unsaturated carboxyl ester functional
group could be used to build the additional functionalized
ring derivative that could lead to the tricyclic architecture
(3) suitable for high-throughput generation of various
analogs. At the time of the proposed plan, it was not clear
that the desirable aza Michael reaction would lead to the
additional ring in either the chair or boat form (see 3.1 and
3.2 in Figure 1). If successful in solution and on the solid
phase, the approach described herein would lead to an
interesting tetrahydroquinoline-derived natural-product-like
tricyclic architecture that could then be subjected to com-
binatorial chemistry to obtain several analogs in a high-
throughput manner.
Our initial approach to obtain the tetrahydroaminoquino-
line-based aldehyde did not provide us the desired product,
6 (Scheme 1), from 4. In our hands, the corresponding
hydroxyl derivative, 5, which was easily obtained from 4,
failed to oxidize under several reaction conditions. As an
alternative, compound 4 was first subjected to side-chain
extension, giving the unsaturated carboxyl derivative 7. after
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the acetonide deprotection and the hydroxyl group protection,
the desired starting material containing an N-Alloc-protected
system was then obtained; this allowed the exploration of
the crucial aza Michael reaction. Interestingly, when com-
pound 7b (not shown in the scheme) was subjected to
N-Alloc removal, there was no sign of the free amine
derivative 8. Instead, the tricyclic product 9 was isolated as
a single diastereomer! The discoVery of an in situ aza
Michael reaction with complete stereocontrol was a pleasant
surprise indeed. To our knowledge, this approach is highly
intriguing and has not been used in the past in related systems
to obtain functionalized polycyclic architectures. These
reaction conditions (i.e., the removal of the N-Alloc group
using Pd(0), PPh3) are very mild, and it would be excellent
if this approach could be developed for the solid phase.
After the discovery of this beautiful in situ cyclization,
the next set of challenges involved the assignment of the
stereochemistry of the newly generated asymmetric center
and the determination of the shape of the additional piperi-
dine ring containing a â-amino acid functionality. Figure 2
shows the four plausible transition states that could be
considered to lead to the product formation. A careful NMR
analysis allowed us to assign the unique structure of
compound 9. In contrast to compound 7, which showed a
NOE between the protons at C2 and C4, the bridged tricyclic
derivative 9 did not show a NOE. This suggested that, in
the starting material 9, the substituents at C2, C3, and C4
occupy the pseudoequatorial positions. The formation of the
bridged compound 9 could be explained as follows: to
proceed with the aza Michael reaction, the substituents at
C2, C3, and C4 adopt a pseudoaxial position to facilitate this
reaction. As shown in Figure 2, there are four plausible
transition states which may be involved in the formation of
the desired product. For steric reasons, the chairlike transition
states are not considered to be favorable (see 10 and 11).
The NOE between the protons at C3 and C7 allowed us to
assign the stereochemistry and to predict a boat-type structure
for the third ring (see Figure 2). A similar product with all
the chair-type ring structures would not show any NOE
between these two protons at C3 and C7. The ease of the
solution-phase method for obtaining this highly functional-
ized, tetrahydroquinoline-based tricyclic derivative, having
a â-amino acid functionality, prompted us to develop this
approach on solid phase. The development of the manual
solid-phase synthesis for further use in the library generation
is shown in Scheme 2.
The starting material for the solid-phase synthesis, com-
pound 15, was obtained from 6 through easy transformations,
and the details are provided in the Experimental Section.
Additional analytical data are also provided in the Supporting
Information.16 When subjecting compound 15 to the standard
loading conditions using Broad Institute alkylsilyl-based
Figure 1. Approach to high-throughput generation of tetrahydroaminoquinoline-based polycyclic architectures (3) from an enantioenriched
scaffold (1).
Scheme 1
a (i) CBz and acetonide deprotection, (ii) alloc protection, (iii) TBSOTf, (iv) LiBH4. b Dess-Martin. c (i) H2, 10% Pd/C; SiO2, 56%, (ii) allocCl, DIPEA,
91%, (iii) 2-methoxypropene, PPTS, molecular sieves 4 Å, 60 °C, 81%, (iv) LiBH4, RT, 81%, (v) Dess-Martin, RT, (vi) Ph3PdCHCOOEt, RT, 87% for
2 steps. d (i) Acetonide removal, (ii) TESOTf, (iii) alloc removal. e Benzoylation. f Cinnamoylation.
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polystyrene macrobeads (560-560 µM, loading capacity
1.365 mmol/g), we were pleased to note that it could be
immobilized in a high yield (85-90% loading determined
after cleavage of the product from the solid support) and
with complete regiocontrol. The hydroxyl group of loaded
compound 16 was then acylated (i.e., first diversity) and
subjected to N-Alloc removal. To our delight, as we observed
in solution synthesis, the in situ formation of the additional
piperidine ring by an aza Michael also worked very well in
the solid phase. The final product, 18, was obtained,
following the three-step sequence that includes (i) N-
amidation, (ii) N-Fmoc removal, and (iii) N-amidation, after
a cleavage from the solid support. The extensive NMR
studies of compound 18 revealed similar results to those
obtained with the product 9a, generated by solution-phase
synthesis. Our successful solid-phase efforts provide an
attractive route to obtain a high-throughput access to several
analogs of tetrahydroquinoline-based bridged tricyclic natural-
product-like compounds.
Conclusion
To summarize, herein, we disclose an unprecedented,
stereocontrolled, in situ, aza Michael approach in solution
and on the solid phase to obtain tetrahydroquinoline-derived
bridged tricyclic architectures. Furthermore, work is in
progress to generate a 200-member library by using IRORI
2D-bar coded technology and to develop new small-molecule
microarrays using these library members. In addition, the
scope of these library members as chemical dissectors of
several protein-protein interaction-based signaling networks
will be investigated, and these studies will be reported as
they become available.
Experimental Procedures
All reactions were carried out in flame-dried glassware
under an atmosphere of nitrogen with magnetic stirring. Thin-
layer chromatography (TLC) was done on EMD (Art. 5715-
7) precoated silica gel 60 F254 glass plates (layer thickness
) 0.25 mm). Visualization was affected with a UV lamp
(254 nm) or either by staining with a vanillin, KMnO4, or
ammonium molybdate/ceric sulfate solution. Flash column
chromatography was performed using silica gel 60 (40-63
µm, Silicycle) or the Biotage Horizon Flash Chromatography
System. Solvents were purified as follows: the trace amounts
of water and oxygen in THF, DMF, and dichloromethane
were removed using columns containing activated alumina
and copper under N2. Triethylamine, pyridine, ethyl ether,
and toluene were obtained from commercial suppliers (EMD
Figure 2. Proposed transition states to explain the diastereoselective outcome of the aza Michael reaction.
Scheme 2
a (i) pTSA, 60 °C, 96%, (ii) Cs2CO3, 3-bromo-propanol, RT, 58%. b(i) TBAF, RT, 94%, (ii) FmocCl, NaHCO3, RT, 60%, (c) (4-methoxyphenyl)diiso-
propylsilyl propyl polystyrene macrobeads (loading 1.365 mmol/g, 500-560 µm), 75% determined by an increase in the weight of the loaded alkylsilyl
macrobeads. d(i) 3,4-(Methylenedioxy)phenylacetic acid, DCC, DMAP, RT, (ii) Pd(PPh3)4, PPh3, 4-methyl morpholine, CH3CO2H, RT, (iii) PhCOCl, 2,4,6-
collidine, RT, (iv) morpholine, RT, (v) 4-methoxyphenylacetyl chloride, 2,4,6-collidine, RT. eHF pyridine.
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and Aldrich) and used without further purification. NMR
spectra were recorded on a Bruker DRX 400 MHz spec-
trometer. All chemical shifts are reported in parts per million
(δ). 1H NMR (400 MHz) spectra were recorded at room
temperature in CDCl3 or C6D6 solutions and referenced to
residual CHCl3 (7.27 ppm) or C6H6 (7.16 ppm). Fully
decoupled 13C NMR (100 MHz) spectra were recorded in
CDCl3 or C6D6 solutions. The center peaks of CDCl3 (77.0
ppm) and C6D6 (128.7 ppm) were used as the internal
reference. Mass spectra were carried out on a VG Quattro I
(Micromass) mass spectrometer equipped with a pneumati-
cally assisted electrospray ionization source, operating in
positive mode. HPLC were performed using a Hewlett-
Packard (Agilent) 1100 Series equipped with a diode array
detector and a NovaPack C18 (3.9 × 300 mm) column. The
enantiomeric excess was determined by chiral HPLC, using
a Hewlett-Packard (Agilent) 1090 Series II Liquid Chro-
matograph equipped with a diode array detector and a
CHIRACELOD column. HPLC/MS were performed using
Waters equipment: Waters micromass ZQ ESCI multimode
ionization, Waters 996 photodiode array detector (254 nm),
and a Waters 2795 separation module with Phenomenex
Spherisorb 3 ODS-2 column.
Colorless oil. Rf: 0.54 (1/1 hexane/ethyl acetate). 1H NMR
(CDCl3, 400 MHz): δ 7.42-7.26 (m, 5H, Ph), 6.86 (broad
s, 1H, MEMOC-CHdC), 6.78 (dd, J ) 8.5 Hz, J ) 2.3
Hz, 1H, CH-CHdC-N), 6.44 (d, J ) 8.5 Hz, 1H, CH-
CHdC-N), 5.29 (d, J ) 12.3 Hz, 1H, PhCH2OCO), 5.20
(d, J ) 12.3 Hz, 1H, PhCH2OCO), 5.06 (broad s, 2H,
OMEM), 4.47 (d, J ) 9.8 Hz, 1H, CH-NCO), 4.42 (broad
s, 1H, NH), 4.16 (2q, J ) 7.0 Hz, 2H, CO2CH2CH3), 3.95
(td, J ) 9.8 Hz, J ) 2.5 Hz, 1H, CHCH2CO2Et), 3.79-3.74
(m, 2H, OMEM), 3.66 (t, J ) 9.8 Hz, 1H, CHOCMe2),
3.54-3.49 (m, 2H, OMEM), 3.34 (s, 3H, OMEM), 2.84 (dd,
J ) 16.0 Hz, J ) 2.5 Hz, 1H, CHCH2CO2Et), 2.38 (dd, J )
16.0 Hz, J ) 9.8 Hz, 1H, CHCH2CO2Et), 1.66 (broad s, 3H,
CMe2), 1.56 (s, 3H, CMe2), 1.25 (t, J ) 7.0 Hz, 3H, CO2-
CH2CH3). 13C NMR (CDCl3, 100 MHz): δ 171.4, 154.6
(broad), 149.2, 137.0, 135.8, 128.2 (2C), 128.0 (2C), 127.9,
122.9 (broad), 115.7, 114.1 (broad), 113.8, 99.0 (broad), 94.4,
78.5 (broad), 71.4, 67.1, 66.9 (broad), 60.6, 60.1 (broad),
58.7, 52.2, 39.4, 26.1 (broad, 2C), 13.9. LRMS: MS (ES+)
m/z ) 529.4 (M + 1).
Triphosgene (192 mg, 0.63 mmol) was added to the round-
bottom flask and cooled to -78 °C. This was then followed
by the slow addition of 10 mL of anhydrous CH2Cl2, and
the solution was vigorously stirred for 30 min. The 2-(tri-
methylsilyl) ethanol (265 µL, 1.84 mmol) was added to the
reaction mixture in one portion at -78 °C, and the mixture
was then warmed to -10 °C. Then pyridine (150 µL, 1.84
mmol) was added dropwise to the reaction mixture and
stirred for 2 h at -10 °C. The reaction mixture was cooled
to -45 °C, and a solution of free amine (485 mg, 0.92 mmol)
and pyridine (225 µL, 2.75 mmol) in 3 mL of anhydrous
CH2Cl2 was added via cannula over a period of 5 min. The
stirring was continuous for 1 h at -30 °C and for 15 min at
0 °C. When the TLC showed no starting material, the
reaction mixture was quenched via the addition of 40 mL of
a saturated solution of NaHCO3, and the aqueous layer was
extracted with CH2Cl2 (3 × 30 mL). The organic layer was
dried over MgSO4, filtered, and concentrated under vacuum,
and the crude product was chromatographed on neutralized
silica gel with hexane/triethylamine, 9/1 (eluent ) hexane/
ethyl acetate, 8/2) to give 4 (470 mg, 77%) (Figure 4).
Colorless oil. Rf: 0.59 (1/1 hexane/ethyl acetate). 1H NMR
(CDCl3, 400 MHz): δ 7.44-7.23 (m, 6H, 5HPh and CH-
CHdC-N), 6.96 (dd, J ) 8.8 Hz, J ) 2.5 Hz, 1H, CH-
CHdC-N), 6.82 (broad s, 1H, MEMOC-CHdC), 5.30-
5.09 (m, 4H, 2H from OMEM and PhCH2OCO), 4.56 (broad
m, 1H, CHCH2CO2Et), 4.35-4.26 (m, 2H, TMSCH2CH2O),
4.29-4.19 (m, 1H, CH-NCO), 4.10-3.96 (m, 2H, CO2CH2-
CH3), 3.84-3.76 (m, 2H, OMEM), 3.71 (t, J ) 9.5 Hz, 1H,
CHOCMe2), 3.57-3.51 (m, 2H, OMEM), 3.37 (s, 3H,
OMEM), 2.81-2.71 (m, 2H, CHCH2CO2Et), 1.73 (broad s,
3H, CMe2), 1.57 (s, 3H, CMe2), 1.16 (t, J ) 7.0 Hz, 3H,
CO2CH2CH3), 1.06 (broad s, 2H, TMSCH2CH2O), 0.03 (s,
9H, TMS). 13C NMR (CDCl3, 100 MHz): δ 169.5, 154.8,
154.4, 153.7 (broad), 135.7, 132.6 (broad), 128.6, 128.3 (2C),
128.1 (2C), 127.9, 127.1 (broad), 113.8 (broad), 111.1
(broad), 99.5 (broad), 93.4, 80.4 (broad), 71.3, 67.4, 66.9
(broad), 64.3, 60.3, 59.5, 58.7, 54.3, 37.9 (broad), 25.8
Figure 3.
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(broad, 2C), 17.5, 13.7, -1.8 (3C). LRMS: MS (ES+) m/z
) 673.5 (M + 1).
Palladium 10 wt % on activated carbon (63 mg) was added
to a solution of Teoc-protected amine (503 mg, 075 mmol)
in 15 mL of anhydrous ethanol, and the mixture was stirred
for 8.5 h in a hydrogen atmosphere. The reaction mixture
was filtered through celite and concentrated under vacuum.
The crude product was chromatographed on silica gel
(eluent: CH2Cl2/methanol, 98/2) to give 4a (210 mg, 56%).
Colorless oil. Rf: 0.16 (98/2 CH2Cl2/methanol). 1H NMR
(CDCl3, 400 MHz): δ 7.26 (broad d, J ) 8.5 Hz, 1H, CH-
CHdC-N), 7.05 (d, J ) 2.5 Hz, 1H, MEMOC-CHdC),
6.89 (dd, J ) 8.5 Hz, J ) 2.5 Hz, 1H, CH-CHdC-N),
5.24-5.19 (m, 2H, OMEM), 4.46-4.44 (m, 1H, CHCH2-
CO2Et), 4.28-4.12 (m, 2H, TMSCH2CH2O), 4.05-3.95 (m,
2H, CO2CH2CH3), 3.80-3.75 (m, 2H, OMEM), 3.65 (t, J
) 9.8 Hz, 1H, CHOH), 3.54-3.49 (m, 2H, OMEM), 3.33
(s, 3H, OMEM), 3.20 (ddd, J ) 9.8 Hz, J ) 6.0 Hz, J ) 3.3
Hz, 1H, CHNH2), 2.74-2.64 (m, 1H, OH), 2.71 (dd, J )
15.3 Hz, J ) 4.5 Hz, 1H, CHCH2CO2Et), 2.52 (dd, J ) 15.3
Hz, J ) 8.5 Hz, 1H, CHCH2CO2Et), 2.01 (broad s, 2H, NH2),
1.14 (t, J ) 7.0 Hz, 3H, CO2CH2CH3), 0.99 (t, J ) 8.5 Hz,
2H, TMSCH2CH2O), -0.03 (s, 9H, TMS). 13C NMR (CDCl3,
100 MHz): δ 171.9, 155.0, 154.3, 135.1, 129.3, 126.3, 114.3,
111.1, 93.5, 78.8, 71.4, 67.4, 64.2, 60.7, 58.8, 57.4, 53.0,
38.7, 17.6, 13.9, -1.7 (3C). LRMS: MS (ES+) m/z ) 499.4
(M + 1).
N,N-Diisopropylethylamine (135 µL, 0.77 mmol), one por-
tion, and allylchloroformate (77 µL, 0.71 mmol), dropwise,
were added to a solution of free amine 4a (320 mg, 0.64
mmol) in 50 mL of anhydrous CH2Cl2 at -70 °C. The
reaction mixture was slowly warmed to room temperature
in 3 h, stirred for an additional 2.5 h, and quenched via the
addition of 40 mL of a saturated solution of NH4Cl. The
aqueous layer was extracted with CH2Cl2 (3 × 30 mL), and
the organic layer was dried over MgSO4. After filtration and
concentration under vacuum, the crude product was chro-
matographed on silica gel (eluent ) CH2Cl2/methanol, 98/
2) to give 4b (340 mg, 91%). Colorless oil. Rf: 0.19 (1/1
hexane/ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ 7.27
(broad d, J ) 8.8 Hz, 1H, CH-CHdC-N), 6.94 (dd, J )
8.8 Hz, J ) 2.5 Hz, 1H, CH-CHdC-N), 6.92 (broad s,
1H, MEMOC-CHdC), 6.00-5.87 (m, 1H, H2CdCH-
CH2O), 5.36 (broad d, J ) 7.5 Hz, 1H, NH), 5.33 (broad d,
J ) 17.1 Hz, 1H, H2CdCH-CH2O), 5.24-5.20 (m, 1H,
H2CdCH-CH2O), 5.25-5.19 (m, 2H, OMEM), 4.70-4.62
(m, 1H, CH-NH), 4.62 (d, J ) 5.5 Hz, 2H, H2CdCH-
CH2O), 4.62-4.56 (m, 1H, CHCH2CO2Et), 4.32-4.16 (m,
2H, OCH2CH2TMS), 4.10-3.97 (m, 2H, CO2CH2CH3), 3.93
(broad s, 1H, OH), 3.80 (dd, J ) 6.0 Hz, J ) 4.5 Hz, 2H,
OMEM), 3.61-3.54 (m, 1H, CH-OH), 3.55 (dd, J ) 6.0
Hz, J ) 4.5 Hz, 2H, OMEM), 3.36 (s, 3H, OMEM), 2.73
(dd, J ) 15.1 Hz, J ) 4.8 Hz, 1H, CHCH2CO2Et), 2.54 (dd,
J ) 15.1 Hz, J ) 8.3 Hz, 1H, CHCH2CO2Et), 1.17 (t, J )
7.0 Hz, 3H, CO2CH2CH3), 1.03 (t, J ) 8.5 Hz, 2H,
OCH2CH2TMS), 0.01 (s, 9H, TMS). 13C NMR (CDCl3, 100
MHz): δ 171.8, 156.7, 154.9, 154.4, 132.6, 131.8, 129.3,
126.7, 117.9, 114.9, 111.8, 93.6, 76.4, 71.5, 67.5, 66.0, 64.5,
60.9, 58.9, 57.1, 53.8, 38.4, 17.7, 13.9, -1.62 (3C). LRMS:
MS (ES+) m/z ) 583.4 (M + 1).
2-Methoxypropene (0.79 mL, 8.02 mmol) was added to a
solution of the alloc-protected compound 4b (468 mg, 0.80
mmol) in 10 mL of toluene, and the mixture was stirred for
15 min. Molecular sieves (4 Å, 50 mg) and pyridinium
p-toluenesulfonate (10 mg, 0.04 mmol) were then added to
the reaction mixture, and the mixture was warmed to 60 °C
for 140 min. The reaction mixture was cooled, filtered, and
concentrated under vacuum. The crude product was chro-
matographed using the Biotage chromatograph system (A
) hexane, B ) ethyl acetate, CV ) 48 mL, vol fract ) 15
mL, flow ) 19 mL/min, neutralization of the column using
2 CV with hexane/triethylamine, 9/1, EQ[5CV] 10%B, 1CV1
10%B, 10CV2 10%B to 40%B, 10CV3 40%B) to give the
title compound (404 mg, 81%). Colorless oil. Rf: 0.60 (1/1
hexane/ethyl acetate using neutralized TLC silica plate with
triethylamine). 1H NMR (CDCl3, 400 MHz): δ 7.17 (broad
s, 1H, CH-CHdC-N), 6.85 (dd, J ) 8.8 Hz, J ) 2.5 Hz,
1H, CH-CHdC-N), 6.74 (d, J ) 2.5 Hz, 1H, MEMOC-
CHdC), 5.85 (broad s, 1H, H2CdCH-), 5.26-5.05 (m, 4H,
OMEM and H2CdCH-), 4.58 (broad s, 2H, H2CdCH-
CH2O), 4.46 (broad s, 1H, CHCH2CO2Et), 4.26-4.14 (m,
2H, TMSCH2CH2O), 4.17-4.08 (m, 1H, CH-NCO), 3.99-
3.86 (m, 2H, CO2CH2CH3), 3.74-3.70 (m, 2H, OMEM),
3.61 (t, J ) 9.5 Hz, 1H, CHOCMe2), 3.48-3.44 (m, 2H,
OMEM), 3.27 (s, 3H, OMEM), 2.70-2.62 (m, 2H, CHCH2-
CO2Et), 1.62 (broad s, 3H, CMe2), 1.47 (s, 3H, CMe2), 1.06
(t, J ) 7.3 Hz, 3H, CO2CH2CH3), 0.97 (broad s, 2H,
Figure 4. NOE between H2 and H4 for compound 4.
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TMSCH2CH2O), -0.07 (broad s, 9H, TMS). 13C NMR
(CDCl3, 100 MHz): δ 169.4, 154.8, 154.3, 153.3 (broad),
132.6 (broad), 132.1, 128.5, 127.0 (broad), 118.0, 113.8
(broad), 110.9 (broad), 99.3 (broad), 93.4, 80.3 (broad), 71.3,
67.3, 65.9 (broad), 64.2, 60.2, 59.4 (broad), 58.6, 54.3, 37.9
(broad), 25.7 (broad, 2C), 17.4, 13.7, -1.9 (3C). LRMS: MS
(ES+) m/z ) 623.6 (M + 1). HPLC: 12.59 min.
A 2 M lithium borohydride solution in THF (0.80 mL, 1.61
mmol) was added to a solution of ester 4c (400 mg, 0.64
mmol) in 5 mL of anhydrous THF at room temperature, and
the mixture was stirred for 15 h. Then more lithium
borohydride solution in THF (2.00 mL, 4.00 mmol) was
added and stirred for an additional 2 h. The reaction mixture
was quenched by reverse addition onto ice-cold saturated
NH4Cl solution. The aqueous layer was extracted with Et2O
(3 × 20 mL), and the organic layer was dried over MgSO4.
After filtration and concentration under vacuum, the crude
product was chromatographed using the Biotage chromato-
graph system (A ) hexane, B ) ethyl acetate, CV ) 48
mL, vol fract ) 42 mL, flow ) 19 mL/min, neutralization
of the column using 2 CV with hexane/triethylamine, 9/1,
EQ[5CV] 10%B, 1CV1 10%B, 10CV2 10%B to 50%B,
10CV3 50%B) to give the title compound (301 mg, 81%).
Colorless oil. Rf: 0.45 (1/1 hexane/ethyl acetate using
neutralized TLC silica plate with triethylamine). 1H NMR
(CDCl3, 400 MHz): δ 7.13 (broad s, 1H, CH-CHdC-N),
6.90 (dd, J ) 8.8 Hz, J ) 2.5 Hz, 1H, CH-CHdC-N),
6.80 (d, J ) 2.5 Hz, 1H, MEMOC-CHdC), 5.90 (broad s,
1H, H2CdCH-), 5.35-5.06 (m, 4H, OMEM and H2Cd
CH-), 4.63 (broad s, 2H, H2CdCH-CH2O), 4.38 (broad s,
1H, CHCH2CO2Et), 4.28-4.18 (m, 2H, TMSCH2CH2O),
4.15 (m, 1H, CH-NCO), 3.79-3.75 (m, 2H, OMEM),
3.73-3.60 (m, 2H, CHCH2CH2OH), 3.54-3.49 (m, 2H,
OMEM), 3.42-3.33 (broad m, 1H, CHOCMe2), 3.32 (s, 3H,
OMEM), 3.03 (broad s, 1H, OH), 1.87 (broad s, 1H, CHCH2-
CH2OH), 1.75-1.56 (m, 1H, CHCH2CH2OH), 1.67 (broad
s, 3H, CMe2), 1.52 (s, 3H, CMe2), 0.95 (broad s, 2H,
TMSCH2CH2O), -0.05 (broad s, 9H, TMS). 13C NMR
(CDCl3, 100 MHz): δ 155.9 (broad), 155.3 (broad), 153.5
(broad), 133.5 (broad), 132.2, 128.3 (broad), 127.7 (broad),
118.2, 113.9 (broad), 111.3 (broad), 99.5 (broad), 93.5, 83.0
(broad), 71.4, 67.5, 66.1 (broad), 64.6 (broad), 59.6, 58.8,
58.5 (broad), 54.3 (broad), 37.6, 25.9 (broad, 2C), 17.4, -1.8
(3C). LRMS: MS (ES+) m/z ) 581.6 (M + 1). HPLC:
11.43 min.
Compound 4e.
Dess-Martin reagent (272 mg, 0.62 mmol) was added to a
solution of alcohol 4d (301 mg, 0.52 mmol) in 5 mL of
anhydrous CH2Cl2 at room temperature, and the mixture was
stirred for 1 h. Then 10 mL of a saturated solution of
NaHCO3 was added; the aqueous layer was extracted with
CH2Cl2 (3 × 10 mL), and the organic layer was dried over
MgSO4. After filtration and concentration under vacuum, the
crude aldehyde was used for the next reaction without
purification. Yellow oil. Rf: 0.58 (1/1 hexane/ethyl acetate
using neutralized TLC silica plate with triethylamine).
LRMS: MS (ES+) m/z ) 579.5 (M + 1), 596.6 (M + 18).
HPLC: 11.76 min.
Compound 7.
The (carbethoxymethylene) triphenylphosphorane (285 mg,
0.78 mmol) was added to a solution of crude aldehyde 4e in
10 mL of anhydrous CH2Cl2, and the reaction mixture was
stirred for 5 h. Then 20 mL of a saturated solution of Na2-
CO3 was added; the aqueous layer was extracted with CH2-
Cl2 (3 × 20 mL), and the organic layer was dried over
MgSO4. After filtration and concentration under vacuum, the
crude product was chromatographed using the Biotage
chromatograph system (A ) hexane, B ) ethyl acetate, CV
) 48 mL, vol fract ) 42 mL, flow ) 19 mL/min,
neutralization of the column using 2 CV with hexane/
triethylamine, 9/1, EQ[5CV] 10%B, 1CV1 10%B, 10CV2
10%B to 40%B, 10CV3 40%B) to give the title compound
(295 mg, 87% for 2 steps). Colorless oil. Rf: 0.62 (1/1
hexane/ethyl acetate using neutralized TLC silica plate with
triethylamine). 1H NMR (CDCl3, 400 MHz): δ 7.40-7.06
(broad m, 1H, CH-CHdC-N), 6.89 (dd, J ) 8.8 Hz, J )
2.0 Hz, 1H, CH-CHdC-N), 6.79 (dt, J ) 15.6 Hz, J )
7.5 Hz, 1H, CHdCHCO2Et), 6.77 (d, J ) 2.0 Hz, 1H,
MEMOC-CHdC), 5.88 (broad s, 1H, H2CdCH-), 5.79 (d,
J ) 15.6 Hz, 1H, CHdCHCO2Et), 5.31-5.07 (m, 4H,
OMEM and H2CdCH-), 4.61 (broad s, 2H, H2CdCH-
CH2O), 4.35 (broad s, 1H, CHCH2CHdCHCO2Et), 4.27-
4.13 (m, 3H, TMSCH2CH2O and CH-NCO), 4.13-4.03 (m,
2H, CO2CH2CH3), 3.78-3.73 (m, 2H, OMEM), 3.52-3.48
(m, 2H, OMEM), 3.36 (t, J ) 9.3 Hz, 1H, CHOCMe2), 3.31
(s, 3H, OMEM), 2.71-2.61 (m, 1H, CHCH2CHdCHCO2-
Et), 2.61-2.51 (broad m, 1H, CHCH2CHdCHCO2Et), 1.65
(broad s, 3H, CMe2), 1.49 (s, 3H, CMe2), 1.19 (t, J ) 7.0
Hz, 3H, CO2CH2CH3), 0.99 (broad s, 2H, TMSCH2CH2O),
-0.03 (broad s, 9H, TMS). 13C NMR (CDCl3, 100 MHz):
δ 165.6, 155.0, 154.6, 153.5 (broad), 142.9, 132.9 (broad),
132.2, 128.7, 128.3 (broad), 127.2 (broad), 124,1, 118.2,
113.9 (broad), 111.1 (broad), 99.4 (broad), 93.5, 80.9 (broad),
71.4, 67.5, 66.0 (broad), 64.3, 59.9, 59.5 (broad), 58.8, 55.8
(broad), 35.8 (broad), 25.9 (broad, 2C), 17.5 (broad), 14.0,
-1.8 (2C). LRMS: MS (ES+) m/z ) 649.7 (M + 1), 621.6
(M - 27), 581.4 (M - 67). HPLC: 12.70 min.
Natural-Product-like Architectures Journal of Combinatorial Chemistry, 2006, Vol. 8, No. 5 767
Compound 7a.
A solution of acetic acid/THF/water (8/1/1, 5.0 mL) was
added to compound 9 (100 mg) at room temperature, and
the mixture was stirred for 24 h. Again, 3 mL of the above-
mentioned solution was added to the reaction mixture, and
it was stirred for another 24 h. The reaction mixture was
extracted with ethyl acetate (3 × 30 mL) and dried over
anhydrous MgSO4. The solvent was removed under reduced
pressure, and the crude product was purified by flash column
chromatography using 45/55 ethyl acetate/hexane to obtain
compound 7a (80 mg, 85%). Molecular Formula: C29H44-
N2O10Si. LRMS: MS (ES+) m/z ) 609 (M + 1). 1H NMR
(400 MHz, CDCl3): δ 7.36 (br d, 1H, J ) 9.0 Hz, CHCH-
C-N), 7.03-6.97 (dd, 1H, J ) 8.7 Hz and 3.0 Hz, CHCH-
C-N), 6.92 (br d, 1H, J ) 2.0 Hz, MEMOCdCH-C),
6.91-6.84 (m, 1H, CHdCHCO2Et), 6.02-5.92 (m, 1H,
OCH2CHdCH2), 5.80 (d, 1H, J ) 15.5 Hz, CHdCHCO2-
Et), 5.37 (d, 1H, J ) 16.8 Hz, OCH2CHdCH2), 5.31-5.24
(m, 3H, 1H from OCH2CHdCH2 and MEM), 5.12 (br d,
1H, J ) 8.7 Hz, NHCHCH), 4.72-4.62 (m, 3H, NH, OCH2-
CHdCH2), 4.53-4.45 (m, 1H, NCHCH2), 4.33-4.21 (q, 2H,
J ) 9.5 Hz, TMSCH2CH2O), 4.20-4.11 (q, 2H, J ) 7.2
Hz, CO2CH2CH3), 3.84 (m, 2H, MEM), 3.58 (m, 2H, MEM),
3.50-3.42 (m, 1H, CHOH), 3.39 (s, 3H, MEM), 2.62-2.53
(m, 1H, NCHCH2), 2.52-2.42 (m, 1H, NCHCH2), 1.27 (t,
3H, CO2CH2CH3), 1.06 (t, 2H, TMSCH2CH2O), 0.07-0.00
(br s, 9H, TMS). 13C NMR (400 MHz, CDCl3): δ 166.42,
151.13, 155.33, 155.13, 144.17, 132.80, 131.40, 130.11,
127.66, 124.52, 118.72, 115.91, 112.04, 94.08, 77.63, 71.99,
68.05, 66.71, 65.08, 60.70, 59.46, 59.11, 54.69, 36.61, 18.14,
14.60, -1.11(3C).
Compound 7b.
Pyridine (16.1 µL, 0.19 mmol) was added to a solution of
compound 7a (80 mg, 0.13 mmol) in 40 mL of dry CH2Cl2,
cooled to -40 °C, followed by the addition of TESOTf (39.1
µL, 0.17 mmol). The reaction mixture was allowed to stir at
-40 °C for 3.5 h. The reaction mixture was then quenched
with saturated NaHCO3, extracted with CH2Cl2 (3 × 30 mL),
and dried over anhydrous MgSO4. The solvent was removed
under reduced pressure, and the crude product was purified
by flash column chromatography using 30/70 ethyl acetate/
hexane to obtain compound 7b (55 mg, 84%). Molecular
Formula: C35H58N2O10Si2. LRMS: MS (ES+) m/z ) 723
(M + 1). 1HNMR (400 MHz, CDCl3): δ 7.49-7.33 (m,
1H, CHCH-C-N), 7.03-6.97 (dd, 1H, J ) 8.7 Hz, J )
2.7 Hz, CHCH-C-N), 6.96 (br s, 1H, MEMOCdCH-C),
6.91-6.82 (m, 1H, CHdCHCO2Et), 6.02-5.92 (m, 1H,
OCH2CHdCH2), 5.77 (d, 1H, J ) 15.8 Hz, CHdCHCO2-
Et), 5.36 (br d, 1H, J ) 17.3 Hz, OCH2CHdCH2), 5.28-
5.24 (m, 3H, 1H from OCH2CHdCH2 and MEM), 4.76 (br
d, 1H, J ) 8.0 Hz, NHCHCH), 4.70-4.60 (m, 3H, NH,
OCH2CHdCH2), 4.59-4.53 (m, 1H, NCHCH2), 4.29-4.14
(m, 4H, TMSCH2CH2O, CO2CH2CH3), 3.88-3.79 (m, 3H,
CHOTES, 2H from MEM), 3.61-3.55 (m, 2H, MEM), 3.40
(s, 3H, MEM), 2.47-2.39 (m, 1H, NCHCH2), 2.28-2.21
(m, 1H, NCHCH2), 1.29 (t, 3H, J ) 7.2 Hz, CO2CH2CH3),
1.09-1.00 (m, 2H, TMSCH2CH2O), 1.00-0.93 (br t, 9H, J
) 7.7 Hz, TES), 0.71-0.60 (br q, 6H, TES), 0.08-0.00 (br
s, 9H, TMS).
Compound 9.
Morpholine (13µL, 0.14 mmol) was added to a solution of
compound 7b (54 mg, 0.07 mmol) in 30 mL of dry CH2Cl2
at room temperature, followed by the addition of Pd(PPh3)4
(8.5 mg, 0.007 mmol), and the mixture was stirred vigorously
for 1 h. The solvent was removed under reduced pressure,
and the crude product was purified by flash column chro-
matography using 45/55 ethyl acetate/hexane to give 9 (44
mg, 92%). Molecular Formula: C31H54N2O8Si2. LRMS: MS
(ES+) m/z ) 639 (M + 1). 1HNMR (400 MHz, CDCl3): δ
8.27 (br d, 1H, J ) 10.0 Hz, CHCH-C-N), 7.18 (m, 1H,
MEMOCdCH-C), 7.12 (br d, 1H, J ) 10.0 Hz, CHCH-
C-N), 5.35-5.23 (m, 3H, NH, MEM), 4.87 (m, 1H,
NHCHCH-O), 4.78(m, 1H, TeocNCHCH2), 4.50 (m, 1H,
CHOTES), 4.33 (t, 2H, J ) 8.0 Hz, TMSCH2CH2O), 4.18-
4.06 (br q, 2H, CO2CH2CH3), 3.84 (m, 2H, MEM), 3.59 (m,
2H, MEM), 3.39 (s, 3H, MEM), 3.23 (m, 1H, CHCH2CO2-
Et), 2.68 (br d, 1H, J ) 11.5 Hz, CHCH2CO2Et), 2.54 (m,
1H, CHCH2CO2Et), 2.28 (m 2H, TeocNCHCH2), 1.22 (t,
3H, J ) 7.0 Hz, CO2CH2CH3), 1.10 (m, 2H, TMSCH2CH2O),
0.92-0.83 (t, 9H, J ) 7.5 Hz, TES), 0.70-0.56 (br q, 6H,
TES), 0.12-0.02 (br s, 9H, TMS). 13C NMR (400 MHz,
CDCl3): δ 172.03, 156.56, 153.28, 136.04, 133.96, 121.77,
117.06, 116.07, 94.25, 77.63, 72.03, 67.89, 64.53, 60.90,
59.43, 57.34, 54.63, 43.04, 40.48, 37.31, 18.21, 14.54, 7.07
(3C), 5.18 (3C), -1.08 (3C).
Compound 9a.
Triethyl amine (6.5 µL, 0.046 mmol), followed by benzoyl
chloride (3.6 µL, 0.031 mmol), was added to a solution of
compound 9 (10 mg, 0.015 mmol) in 10 mL of dry CH2Cl2,
cooled to 0 °C. The reaction mixture was allowed to stir
from 0 °C to room temperature for 3.5 h. The reaction
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mixture was then quenched with saturated NaHCO3, ex-
tracted with CH2Cl2 (3 × 30 mL), and dried over anhydrous
MgSO4. The solvent was removed under reduced pressure,
and the crude product was purified by flash column chro-
matography using 30/70 ethyl acetate/hexane to obtain
compound 9a (7 mg, 60%). Molecular Formula: C38H58N2O9-
Si2. LRMS: MS (ES+) m/z ) 743 (M + 1). 1HNMR (400
MHz, CDCl3): δ 8.09 (br d, 1H, J ) 8.5 Hz, CHCH-C-
N), 7.74 (m, 2H, Ph), 7.56-7.47 (m, 3H, Ph), 7.01-6.97
(dd, 1H, J ) 9.5 Hz, J ) 3.0 Hz, CHCH-C-N), 6.64 (d,
1H, J ) 3.0 Hz, MEMOCdCH-C), 5.21 (m, 2H, MEM),
4.80 (m, 1H, TeocNCHCH2), 4.67 (m, 1H, PhCOHCHCH),
4.29 (t, 2H, J ) 8.0 Hz, TMSCH2CH2O), 4.12 (t, 1H, J )
3.5 Hz, CHOTES), 4.08 (q, 2H, J ) 7.0 Hz, CO2CH2CH3),
3.84 (m, 2H, MEM), 3.60 (m, 2H, MEM), 3.46 (m, 1H,
CHCH2CO2Et), 3.39 (s, 3H, MEM), 3.02 (dd, 1H, J ) 16.5
Hz, J ) 5.5 Hz, CHCH2CO2Et), 2.85 (dd, 1H, J ) 16.0 Hz,
J ) 6.0 Hz, CHCH2CO2Et), 2.17 (m 2H, TeocNCHCH2),
1.19 (t, 3H, J ) 7.0 Hz, CO2CH2CH3), 1.09 (m, 2H,
TMSCH2CH2O), 0.74 (t, 9H, J ) 7.5 Hz, TES), 0.42 (br q,
6H, TES), 0.07 (br s, 9H, TMS). 13C NMR (400 MHz,
CDCl3): δ 174.87, 171.60, 155.54, 153.25, 137.36, 133.58,
131.22, 129.35 (2C), 128.42 (2C), 127.69, 123.97, 122.80,
116.82, 94.23, 72.00, 68.00, 65.90, 64.77, 60.67, 59.59,
59.46, 53.81, 46.29, 38.64, 36.76, 18.20, 14.57, 6.94 (3C),
4.95 (3C), -1.08 (3C).
Compound 9b.
Triethyl amine (4.3 µL, 0.031 mmol), followed by cinnamoyl
chloride (3.8 mg, 0.023 mmol), was added to a solution of
compound 9 (10 mg, 0.015 mmol) in 10 mL of dry CH2Cl2,
cooled to 0 °C. The reaction mixture was allowed to stir
from 0 °C to room temperature for 3.5 h. The reaction
mixture was then quenched with saturated NaHCO3, ex-
tracted with CH2Cl2 (3 × 30 mL), and dried over anhydrous
MgSO4. The solvent was removed under reduced pressure,
and the crude product was purified by flash column chro-
matography using 25/75 ethylacetate/hexane to obtain com-
pound 9b (13 mg, 80%) (Figures 5 and 6). Molecular
Formula: C40H60N2O9Si2. LRMS: MS (ES+) m/z ) 769 (M
+ 1). 1H NMR (400 MHz, CDCl3): δ 7.94 (br d, 1H, J )
9.0 Hz, CHCH-C-N), 7.72 (d, 1H, J ) 15.0 Hz, CHd
CHPh), 7.57 (br d, 2H, J ) 6.0 Hz, Ph), 7.42-7.36 (m, 3H,
Ph), 7.09 (m, 1H, MEMOCdCH-C), 7.03-6.96 (1 set of
d, 1H, J ) 15.0 Hz, CHdCHPh and 1 set of dd, 1H, J )
9.0 Hz, J ) 2.5 Hz, CHCH-C-N), 5.20 (m, 2H, MEM),
5.16 (m, 1H, CONCHCH-O), 4.93 (m, 1H, TeocNCHCH2),
4.31 (t, 2H, J ) 8.5 Hz, TMSCH2CH2O), 4.17-4.09 (m,
3H, CHOTES, CO2CH2CH3), 3.91-3.83 (m, 1H, CHCH2-
CO2Et), 3.81 (t, 2H, J ) 5.0 Hz, MEM), 3.60 (t, 2H, J )
5.0 Hz, MEM), 3.35 (br s, 3H, MEM), 2.97 (dd, 1H, J )
16.0 Hz, J ) 4.0 Hz, CHCH2CO2Et), 2.71-2.63 (dd, 1H, J
) 16.0 Hz, J ) 8.5 Hz, CHCH2CO2Et), 2.27-2.17 (m 1H,
TeocNCHCH2), 2.10-2.02 (t, 1H, TeocNCHCH2), 1.24 (t,
3H, J ) 7.0 Hz, CO2CH2CH3), 1.10 (m, 2H, TMSCH2CH2O),
0.89 (t, 9H, J ) 8.0 Hz, TES), 0.59 (q, 6H, J ) 8.0 Hz,
TES), 0.09 (br s, 9H, TMS). 13C NMR (400 MHz, CDCl3):
δ 173.29, 171.31, 155.70, 153.57, 146.94, 143.88, 135.45,
130.28, 129.29 (2C), 128.67, 128.31 (2C), 124.19, 119.43,
Figure 5. COSY of compound 9b.
Figure 6. NOESY of compound 9b.
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118.13, 116.73, 94.26, 72.00, 68.00, 65.73, 64.75, 61.11,
59.41 (2C), 53.95, 46.50, 41.72, 30.10, 18.20, 14.60, 7.08
(3C), 5.16 (3C), -1.1 (3C).
Starting Material for Solid-Phase Synthesis. Compound
7c.
p-Toluenesulfonic acid monohydrate (80 mg, 0.41 mmol)
was added to a solution of MEM-protected compound 7a
(269 mg, 0.41 mmol) in a mixture of 20 mL of anhydrous
ethanol and 8 mL of anhydrous CH2Cl2 at room temperature.
The reaction mixture was stirred for 13 h at 60 °C. After
the mixture was cooled to room temperature, a saturated
solution of NaHCO3 (10 mL) was added, and the reaction
mixture was concentrated under vacuum to remove the
ethanol. Then CH2Cl2 (10 mL) was added; the aqueous layer
was extracted with CH2Cl2 (3 × 20 mL), and the organic
layer was dried over MgSO4. After filtration and concentra-
tion under vacuum, the crude product was chromatographed
using the Biotage chromatograph system (A ) hexane, B )
ethyl acetate, CV ) 48 mL, vol fract ) 42 mL, flow ) 6
mL/min, EQ[5CV] 15%B, 1CV1 15%B, 10CV2 15%B to
60%B, 10CV3 60%B) to give the title compound (208 mg,
96%). White solid. Rf: 0.24 (1/1 hexane/ethyl acetate), 0.48
(3/7 hexane/ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ
7.95-7.52 (broad s, 1H, OH phenol), 7.24-7.08 (broad m,
1H, CH-CHdC-N), 6.82 (dt, J ) 15.3 Hz, J ) 7.3 Hz,
1H, CHdCHCO2Et), 6.69-6.56 (broad m, 2H, CH-CHd
C-N and HOC-CHdC), 5.99-5.90 (broad s, 1H, NH),
5.89-5.72 (m, 1H, H2CdCH-), 5.74 (d, J ) 15.3 Hz, 1H,
CHdCHCO2Et), 5.24 (broad d, J ) 17.1 Hz, 1H, Htrans2Cd
CH-), 5.13 (broad d, J ) 10.6 Hz, 1H, Hcis2CdCH-), 5.12-
5.04 (m, 1H, CH-NHCO), 4.57 (broad t, J ) 8.3 Hz, 1H,
CHOH), 4.55-4.46 (m, 2H, H2CdCH-CH2O), 4.44-4.30
(broad m, 1H, CHCH2CHdCHCO2Et), 4.25-4.12 (broad m,
2H, TMSCH2CH2O), 4.12-4.02 (m, 2H, CO2CH2CH3), 3.30
(broad s, 1H, OH), 2.58-2.46 (broad m, 1H, CHCH2CHd
CHCO2Et), 2.45-2.33 (broad m, 1H, CHCH2CHdCHCO2-
Et), 1.20 (t, J ) 7.0 Hz, 3H, CO2CH2CH3), 1.05-0.95 (broad
m, 2H, TMSCH2CH2O), -0.02 (s, 9H, TMS). 13C NMR
(CDCl3, 100 MHz): δ 166.6, 157.1, 155.0, 154.1, 144.7,
132.3, 127.3, 126.7 (broad), 123.5, 118.0, 114.5, 110.7
(broad), 110.1 (broad), 75.9 (broad), 66.0, 64.6, 60.4, 58.5
(broad), 54.1 (broad), 36.0 (broad), 17.5, 14.0, -1.7 (3C).
LRMS: MS (ES+) m/z ) 521.4 (M + 1), 493.3 (M - 27).
HPLC: 10.08 min.
Compound 14.
3-Bromo propanol (43 µL, 0.48 mmol) and the phenol
compound 7c (208 mg, 0.40 mmol) were added to a solution
of cesium carbonate (823 mg, 2.53 mmol) in 10 mL of
anhydrous DMF at room temperature via canula (1 mL of
anhydrous DMF was used to wash the round-bottom flasks).
The reaction mixture was stirred for 4 h at room temperature,
and the DMF was removed under vacuum. Et2O (10 mL)
and a solution of NaHCO3 (20 mL) were added, and the
aqueous layer was extracted with Et2O (3 × 30 mL) and
CH2Cl2 (1 × 30 mL). The organic layer was dried over
MgSO4, filtered, and concentrated under vacuum. The crude
product was chromatographed using the Biotage chromato-
graph system (A ) hexane, B ) ethyl acetate, CV ) 48
mL, vol fract ) 42 mL, flow ) 19 mL/min, EQ[5CV] 17%B,
1CV1 17%B, 10CV2 17%B to 70%B, 10CV3 70%B) to give
the title compound (133 mg, 58%). Colorless oil. Rf: 0.29
(3/7 hexane/ethyl acetate), 0.45 (2/8, hexane/ethyl acetate),
1H NMR (CDCl3, 400 MHz): δ 7.25 (broad s, 1H, CH-
CHdC-N), 6.82 (dt, J ) 15.6 Hz, J ) 7.8 Hz, 1H, CHd
CHCO2Et), 6.78-6.70 (broad m, 2H, CH-CHdC-N and
HOC-CHdC), 5.97-5.79 (broad m, 1H, H2CdCH-), 5.82
(broad d, J ) 8.3 Hz, 1H, NH), 5.73 (d, J ) 15.6 Hz, 1H,
CHdCHCO2Et), 5.29 (d, J ) 17.1 Hz, 1H, Htrans2CdCH-
), 5.17 (d, J ) 10.3 Hz, 1H, Hcis2CdCH-), 4.60-4.51 (broad
m, 3H, CH-NHCO and H2CdCH-CH2O), 4.44-4.36
(broad m, 1H, CHCH2CHdCHCO2Et), 4.25-4.12 (m, 3H,
CHOH and TMSCH2CH2O), 4.08 (q, J ) 7.0 Hz, 2H,
CO2CH2CH3), 4.06-3.96 (broad m, 2H, HOCH2CH2CH2),
3.75 (broad t, J ) 5.8 Hz, 2H, HOCH2CH2CH2), 3.37-3.26
(broad s, 1H, OH), 2.59-2.49 (broad m, 1H, CHCH2CHd
CHCO2Et), 2.57 (broad s, 1H, HOCH2CH2CH2), 2.43-2.33
(broad m, 1H, CHCH2CHdCHCO2Et), 1.99-1.91 (m, 2H,
HOCH2CH2CH2), 1.20 (t, J ) 7.0 Hz, 3H, CO2CH2CH3),
1.04-0.95 (m, 2H, TMSCH2CH2O), -0.01 (s, 9H, TMS).
13C NMR (CDCl3, 100 MHz): δ 166.1, 156.8, 156.4, 154.7,
144.3, 132.6, 132.0, 128.4, 126.8, 123.6, 117.8, 113.0, 109.9,
76.0, 65.9, 65.4, 64.4, 60.1, 59.5, 58.6, 54.3, 36.2 (broad),
31.9, 17.5, 14.1, -1.7 (3C). LRMS: MS (ES+) m/z ) 579.5
(M + 1), 551.4 (M - 27). HPLC: 10.45 min.
Compound 14b.
A solution of TBAF (460 µL, 0.46 mmol) was added to a
solution of Teoc-protected compound 14a (133 mg, 0.23
mmol) in 10 mL of anhydrous THF at room temperature.
The reaction mixture was stirred for 4.5 h at room temper-
ature, and then brine (10 mL) was added. The aqueous layer
was extracted with Et2O (3 × 20 mL) and CH2Cl2 (1 × 20
mL). The organic layer was dried over MgSO4, filtered, and
concentrated under vacuum. The crude product was chro-
matographed using the Biotage chromatograph system (A
) hexane, B ) ethyl acetate, CV ) 12 mL, vol fract ) 30
mL, flow ) 9 mL/min, EQ[5CV] 17%B, 1CV1 17%B,
10CV2 17%B to 70%B, 10CV3 70%B) to give the title
compound (94 mg, 94%). White solid. Rf: 0.30 (2/8 hexane/
ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ 6.97 (ddd, J
) 15.8 Hz, J ) 2.5 Hz, J ) 8.5 Hz, 1H, CHdCHCO2Et),
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6.70 (d, J ) 2.3 Hz, 1H, CH2OC-CHdC), 6.63 (dd, J )
8.5 Hz, J ) 2.3 Hz, 1H, CH-CHdC-NH), 6.44 (d, J )
8.5 Hz, 1H, CH-CHdC-NH), 5.98 (d, J ) 15.8 Hz, 1H,
CHdCHCO2Et), 5.93 (ddt, J ) 17.1 Hz, J ) 10.6 Hz, J )
5.5 Hz, 1H, H2CdCH-), 5.43 (broad d, J ) 8.3 Hz, 1H,
CONH), 5.33 (d, J ) 17.1 Hz, 1H, Htrans2CdCH-), 5.23 (d,
J ) 10.6 Hz, 1H, Hcis2CdCH-), 4.82 (t, J ) 8.3 Hz, 1H,
CH-NHCO), 4.61 (broad d, J ) 5.5 Hz, 2H, H2CdCH-
CH2O), 4.19 (q, J ) 7.3 Hz, 2H, CO2CH2CH3), 4.00 (broad
s, 1H, NH), 3.70-3.50 (broad s, 1H, CHOH), 3.98 (t, J )
5.8 Hz, 2H, HOCH2CH2CH2), 3.79 (t, J ) 5.8 Hz, 2H,
HOCH2CH2CH2), 3.50 (dd, J ) 8.5 Hz, J ) 8.3 Hz, 1H,
CHOH), 3.28 (td, J ) 8.5 Hz, J ) 2.5 Hz, 1H, CHCH2-
CHdCHCO2Et), 2.86 (broad dt, J ) 14.6 Hz, J ) 2.5 Hz,
1H, CHCH2CHdCHCO2Et), 2.50-2.35 (broad s, 1H, HOCH2-
CH2CH2), 2.36 (dt, J ) 14.6 Hz, J ) 8.5 Hz, 1H, CHCH2-
CHdCHCO2Et), 1.96 (pent, J ) 5.8 Hz, 2H, HOCH2CH2-
CH2), 1.29 (t, J ) 7.3 Hz, 3H, CO2CH2CH3). 13C NMR
(CDCl3, 100 MHz): δ 166.2, 158.3, 151.8, 145.0, 138.3,
132.4, 124.6, 121.1, 118.2, 115.63, 115.55, 113.5, 74.5, 66.3,
66.2, 60.4, 60.1, 56.3, 55.8, 34.7, 32.0, 14.2. LRMS: MS
(ES+) m/z ) 435.4. HPLC: 8.35 min.
Compound 15.
A solution of 5 N sodium bicarbonate (1 mL) and 9-fluo-
renylmethyl chloroformate (144 mg, 0.54 mmol) were added
to a solution of free amine 14b (94 mg, 0.22 mmol) in 5
mL of ethyl acetate at room temperature. The reaction
mixture was stirred for 20 h at room temperature, and a
solution of NaHCO3 (5 mL) was added. The aqueous layer
was extracted with AcOEt (3 × 10 mL). The organic layer
was dried over MgSO4. After filtration and concentration
under vacuum, the crude product was chromatographed using
the Biotage chromatograph system (A ) hexane, B ) ethyl
acetate, CV ) 12 mL, vol fract ) 42 mL, flow ) 9 mL/
min, EQ[5CV] 20%B, 1CV1 20%B, 10CV2 20%B to 80%B,
10CV3 80%B) to give the title compound (75 mg, 60%).
White solid. Rf: 0.30 (2/8, hexane/ethyl acetate). 1H NMR
(CDCl3, 400 MHz): δ 7.74 (m, 2H, Fmoc), 7.47 (broad s,
2H, Fmoc), 7.41-7.34 (m, 2H, Fmoc), 7.32-7.24 (broad
m, 3H, Fmoc and CH-CHdC-N), 6.75 (broad m, 1H, CHd
CHCO2Et), 6.76-6.60 (broad m, 2H, CH2OC-CHdC and
CH-CHdC-N), 5.96-5.82 (m, 1H, H2CdCH-), 5.67 (d,
J ) 15.3 Hz, 1H, CHdCHCO2Et), 5.49 (broad d, J ) 8.3
Hz, 1H, CONH), 5.30 (d, J ) 17.1 Hz, 1H, Htrans2CdCH-
), 5.20 (d, J ) 10.3 Hz, 1H, Hcis2CdCH-), 4.68-4.61 (m,
2H, Fmoc), 4.60-4.50 (m, 3H, CH-NHCO and H2CdCH-
CH2O), 4.40-4.25 (m, 2H, Fmoc and CHCH2CHdCHCO2-
Et), 4.12 (q, J ) 7.0 Hz, 2H, CO2CH2CH3), 4.12-4.00 (m,
3H, CHOH and HOCH2CH2CH2), 3.83-3.77 (broad m, 2H,
HOCH2CH2CH2), 3.30 (broad s, 1H, CHOH), 2.43-2.20
(broad m, 3H, CHCH2CHdCHCO2Et and HOCH2CH2CH2),
2.03-1.94 (m, 2H, HOCH2CH2CH2), 1.23 (t, J ) 7.0 Hz,
3H, CO2CH2CH3). 13C NMR (CDCl3, 100 MHz): δ 166.1,
156.8, 156,5, 154.4, 143.8, 143.6, 141.31, 141.28, 132.4,
132.3, 128.1, 127.69, 127.65, 127.11, 127.06, 126.9, 124.9,
124.8, 123.8, 119.9 (2C), 118.1, 113.2, 110.0 (broad), 76.0
(broad), 67.3, 66.1, 65.6, 60.3, 59.8, 58.8, 54.1 (broad), 47.2,
35.7 (broad), 31.9, 14.1. LRMS: MS (ES+) m/z ) 6.57.6.
HPLC: 10.54 min.
Solid-Phase Synthesis. Loading. Compound 16.
The resin (25.9 mg, 0.035 mmol of free loading site) and
compound 15 (46.4 mg, 0.071 mmol) were dried on freeze
dryer for 24 h hours. The beads were placed in a vial, and
1 mL of anhydrous CH2Cl2 was added at room temperature
to allow the beads to swell. The solution containing the beads
was gently shaken for 30 min. The CH2Cl2 was then
removed, and a 0.45 M trifluoromethanesulfonate solution
(0.47 mL, 0.2118 mmol) was added to resin and kept for 20
min (shaking gently). The beads and the solution became
an orange-red color. The trifluoromethanesulfonate solution
was removed completely, and the resin was washed with
anhydrous CH2Cl2 twice (1 mL). Then 1 mL of anhydrous
CH2Cl2 was added to the resin, followed by the addition of
2,6-lutidine (33 µL, 0.2824 mmol). The beads became
colorless and were left to stand for 10 min. Compound 16
was dissolved in a minimum of solvent (0.5 mL of anhydrous
CH2Cl2) and added to the resin. The resulting mixture was
gently shaken for 1 h. Then the vial was capped and kept
on a tumble shaker for 12 h. The vial was removed from
the tumble shaker, and the contents were washed with DCM
(5 mL) 3 times, THF 3 times, and DCM, again, 3 times.
Finally, the resin was dried on vacuum pump for 6 h and in
the freeze dryer for 12 h (34 mg, 75%). The compound was
obtained after cleavage of 3 beads. LRMS: MS (ES+) m/z
) 657.6 (M + 1). HPLC: 10.58 min.
Compound 16a.
The compound loaded on resin 16 (34 mg, 0.0348 mmol)
was swelled in 3 mL of anhydrous CH2Cl2 for 30 min. The
solvent was removed and replaced with 1 mL of anhydrous
CH2Cl2. 1,3-Diisopropylcarbodiimide (11 µL, 0.0696 mmol),
3,4-(methylenedioxy)phenylacetic acid (9.6 mg, 0.0522
mmol), and 4-(dimethylamino)-pyridine (0.4 mg, 0.0035
mmol) were added at once to the beads at room temperature.
The mixture was shaken with a tumble shaker for 15 h. The
mixture was filtered; the resin was washed with CH2Cl2 (3
× 5 mL), THF (3 × 5 mL), and CH2Cl2 (3 × 5 mL) and
dried under vacuum overnight. The compound was obtained
after cleavage of 3 beads. LRMS: MS (ES+) m/z ) 819.7
(M + 1), 836.8 (M + 18). HPLC: 12.65 min.
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Compound 16b.
Resin 16a (36 mg, 0.0348 mmol of loaded compound) was
swelled in 3 mL of anhydrous CH2Cl2 for 30 min. The
solvent was removed and replaced with 1 mL of a mixture
of anhydrous CH2Cl2 (5 mL), 4-methyl morpholine (0.32
mL), and acetic acid (0.66 mL). Triphenylphosphine (117.6
mg, 0.4437 mmol) and tetrakis(triphenylphosphine) pal-
ladium (108.1 mg, 0.0926 mmol) were added to the beads
at room temperature. The mixture was shaken with a tumble
shaker for 10 h. The mixture was filtered; the resin was
washed with CH2Cl2 (3 × 5 mL), THF (3 × 5 mL), and
CH2Cl2 (3 × 5 mL) and dried under vacuum overnight. The
compound was obtained after cleavage of 3 beads. LRMS:
MS (ES+) m/z ) 752.5 (M + 1). HPLC: 10.71 min.
Compound 16c.
Resin 16b (31 mg, 0.0348 mmol of loaded compound) was
swelled in 3 mL of anhydrous CH2Cl2 for 30 min. The
solvent was removed and replaced with 1 mL of anhydrous
CH2Cl2. 2,4,6-Collidine (46.5 µL, 0.348 mmol) and benzoyl
chloride (20.4 µL, 0.174 mmol) were added to the beads at
room temperature. The mixture was shaken with a tumble
shaker for 16 h. The mixture was filtered; the resin was
washed with CH2Cl2 (3 × 5 mL), THF (3 × 5 mL), and
CH2Cl2 (3 × 5 mL) and dried under vacuum overnight. The
compound was obtained after cleavage of 2 beads. LRMS:
MS (ES+) m/z ) 839.6 (M + 1), 856.7 (M + 18). HPLC:
12.36 min.
Compound 16d.
Resin 16c (33 mg, 0.0348 mmol of loaded compound) was
swelled in 3 mL of anhydrous DMF for 30 min. The solvent
was removed and replaced with 1 mL of anhydrous DMF.
Morpholine (1 mL) was added to the beads at room
temperature. The mixture was shaken with a tumble shaker
for 7 h. The mixture was filtered; the resin was washed with
THF (3 × 5 mL), CH2Cl2 (3 × 5 mL), THF (3 × 5 mL),
and CH2Cl2 (3 × 5 mL) and dried under vacuum overnight.
The compound was obtained after cleavage of 3 beads.
LRMS: MS (ES+) m/z ) 617.4 (M + 1), 634.4 (M + 18).
HPLC: 9.95 min.
Compound 17.
Resin 16d (30 mg, 0.0348 mmol of loaded compound) was
swelled in 3 mL of anhydrous CH2Cl2 for 30 min. The
solvent was removed and replaced with 1 mL of anhydrous
CH2Cl2. 2,4,6-Collidine (46.5 µL, 0.348 mmol) and 4-meth-
oxyphenylacetyl chloride (27.2 µL, 0.174 mmol) were added
to the beads at room temperature. The mixture was shaken
with a tumble shaker for 24 h. The mixture was filtered; the
resin was washed with CH2Cl2 (3 × 5 mL), THF (3 × 5
mL), and CH2Cl2 (3 × 5 mL) and dried under vacuum
overnight. The compound was obtained after cleavage of 3
beads. Rf: 0.46 (1/9 hexane/ethyl acetate). LRMS: MS
(ES+) m/z ) 765.4 (M + 1), 782.5 (M + 8). HPLC: 10.81
min.
Compound 18.
After cleavage of all resin 17, the crude product was
chromatographed on silica gel (eluent ) hexane/ethyl acetate,
2/8) to give the title compound (9 mg). Light yellow gum.
Rf: (1/9 hexane/ethyl acetate). 1H NMR (CDCl3, 400
MHz): δ 7.69 (dd, J ) 7.8 Hz, J ) 1.5 Hz, 2H, PhCO),
7.55-7.50 (m, 3H, PhCO), 7.19 (d, J ) 8.5 Hz, 2H,
MeOPhCH2), 6.87 (d, J ) 8.5 Hz, 2H, MeOPhCH2), 6.89-
6.82 (m, 2H, OCOCH2Ph), 6.63 (d, J ) 8.0 Hz, 1H, CH-
CHdC-N), 6.49 (broad d, J ) 2.0 Hz, 1H, CH2OC-CHd
C), 6.45 (broad dd, J ) 8.0 Hz, J ) 2.0 Hz, 1H, CH-CHd
C-N), 6.38 (broad d, J ) 2.5 Hz, 1H, OCOCH2Ph), 5.91
(s, 2H, -OCH2O-), 5.24 (broad t, J ) 3.0 Hz, 1H, CH-
NCOPh), 4.98 (broad d, J ) 2.0 Hz, 1H, CH-OCO), 4.13-
3.98 (m, 4H, HOCH2CH2CH2 and CO2CH2CH3), 3.91-3.85
(m, 1H, NCHCH2CHCH2), 3.85 (t, J ) 6.0 Hz, 2H, HOCH2-
CH2CH2), 3.79 (s, 3H, OMe), 3.73 (broad s, 2H, OCOCH2-
Ph), 3.47-3.35 (m, 1H, NCHCH2CHCH2), 3.23 (m, 2H,
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NCOCH2Ph), 2.89 (dd, J ) 16.6 Hz, J ) 5.0 Hz, 1H,
NCHCH2CHCH2), 2.61 (dd, J ) 16.6 Hz, J ) 6.0 Hz, 1H,
NCHCH2CHCH2), 2.18-2.09 (m, 1H, NCHCH2CHCH2),
2.03 (quint, J ) 6.0 Hz, 2H, HOCH2CH2CH2), 1.96-1.85
(m, 1H, NCHCH2CHCH2), 1.92 (broad s, 1H, OH), 1.16 (t,
J ) 7.3 Hz, 3H, CO2CH2CH3). LRMS: MS (ES+) m/z )
765.4 (M + 1), 782.5 (M + 8). HPLC: 10.81 min. 13C NMR
(CDCl3, 100 MHz): δ 174.3, 170.9, 170.7, 158.6, 155.6,
147.7, 146.8, 135.8, 131.3, 130.8, 130.4, 129.9 (2C), 129.0
(2C), 128.5, 128.2 (2C), 126.5, 124.5, 122.2, 115.3, 114.2
(2C), 114.11, 114.06, 113.7, 109.5, 108.2, 101.0, 67.0, 65.6,
60.4, 60.1, 55.3, 55.0, 45.9, 40.5, 38.8, 35.5, 31.9, 29.7, 14.1.
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